Allmed acquires controlling-stake in Pronefro
"I am delighted with this exciting acquisition and welcome the entire Pronefro team to Allmed Group,” Allmed CEO Ahmed Sorour said. “Pronefro was established in 1983 and has a very well respected brand in the bloodlines marketplace for both quality and reliability."
Allmed, which manufactures dialysis products, said the stake in Pronefro will allow it to spread to new markets.
Pronefro has a staff of 75 at its plant in Oporto, Portugal, and 13 employees in Curitiba, Brazil.
Pronefro Portugal and Pronefro Brazil will be renamed Allmed Pronefro PT in Portugal and Allmed Pronefro BR in Brazil.